Disc Medicine News and Activities

Disc Medicine is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Disc Medicine is a company listed under the stock ticker IRON (US).

View the org chart displaying its 29 main executives

Most searched biographies at Disc Medicine

• John Quisel, Chief Executive Officer and Director
• Kevin Bitterman, Director
• Donald Nicholson, Executive Chairman of the Board

Popular executive movements at Disc Medicine

• Lisa Amaya Price has joined the company as Chief Human Resources  (posted on January 13 2026).
• Mona Ashiya, Director, has left the company  (posted on October 8 2025).

Create your alert
to follow the executive moves at Disc Medicine.

Disc Medicine has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Disc Medicine

• Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting | Disc Medicine Inc.
• Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting | Disc Medicine Inc.
• Disc Medicine to Participate in Upcoming Investor Conferences | Disc Medicine Inc.
• Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update | Disc Medicine Inc.
• Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc. | Disc Medicine Inc.
• Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting | Disc Medicine Inc.
• Press Releases | Disc Medicine Inc.
• Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval | Disc Medicine Inc.
• Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP) | Disc Medicine Inc.
• Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week | Disc Medicine Inc.
• View more press releases Close

Social media about Disc Medicine

• Disc Medicine on Wikipedia, Google News & Yahoo Finance
• Disc Medicine on LinkedIn, X (Twitter) & YouTube